Skip to content
DataLookout
Menu

PrePOURTSNCT06262048

Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial

StatusUnknown
PhasePhase 2
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
  2. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Dec 30, 2024 to Dec 30, 2025
    • Start date changed from estimate of Jul 1, 2024 to Oct 1, 2024
    • Study completion date: May 31, 2025 to Feb 1, 2026
    • Site details revised
  3. Notable Start date: Apr 1, 2024 to Jul 1, 2024v2 Show 5 more changesShow less
    • Eligibility criteria expanded, about 83 words
    • Primary endpoints: 1 to 3
    • Enrollment target: 64 to 60
    • Primary completion date: Apr 30, 2025 to Dec 30, 2024
    • Study description shortened, about 24 words
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Enrollment Effectiveness
Timeframe: 4 months
Monthly recruitment
Timeframe: 4 months
Protocol adherence
Timeframe: 4 Months

Secondary (6)

Rate of Straight Catheterizations
Rate of Indwelling Catheterizations
Time to first catheterization
Treatment Related Adverse Events
Catheter related complications
Show 1 moreShow less
Length of stay

Arms and interventions

TreatmentExperimental

Tamsulosin

PlaceboPlacebo comparator

Placebo

Drugs: Tamsulosin Hydrochloride

Other: Placebo

Sites

1 site in 1 country

  • London Health Sciences CentreLondon, Ontario, Canada